Riskpilot← Back to searchSign inGet full accessKiwok Development AB
ABActiveOrg 5567702807Norrtullsgatan 57Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20081 employees
Revenue 2024
SEK 0
EBITDA margin
—
+30% vs 2023
Equity ratio
5.7%
Financial strength
Net profit 2024
SEK -1,5M
+30% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -1,5M | +30% |
| Net profit | SEK -1,5M | +30% |
| Total assets | SEK 14,5M | +7% |
| Equity | SEK 825K | +0% |
| Employees | 1 | — |
Legal name
Kiwok Development AB
Org number
5567702807
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
20 november 2008
Share capital
SEK 105 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Bolaget skall, direkt eller indirekt, bedriva utveckling, produktion och försäljning av medicinsktekniska produkter och tjänster avsedda för medicinsk prevention, diagnostik och uppföljning samt bedriva därmed förenlig verksamhet.
Address
Norrtullsgatan 57
Phone
+4684407170
Email
anders.oestlund@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0 | 0 | 0 | 30 | 15 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | −865 | −838 | — |
| EBITDA | 528 | −1 401 | −1 925 | −2 297 | −1 898 | −2 197 | −1 277 | −1 609 | −2 151 | −1 514 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — | — | −0 |
| EBIT | 528 | −1 401 | −1 925 | −2 297 | −1 898 | −2 197 | −1 277 | −1 609 | −2 151 | −1 514 |
| Net financials | −64 | −62 | −61 | −8 | −2 | −92 | −99 | 719 | 0 | — |
| Profit before tax | 465 | −1 462 | −1 986 | −2 305 | −1 900 | −2 289 | −1 375 | −890 | −2 151 | −1 514 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — | — | −0 |
| Net profit | 465 | −1 462 | −1 986 | −2 305 | −1 900 | −2 289 | −1 375 | −890 | −2 151 | −1 514 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3 350 | 4 479 | 6 219 | 7 186 | 8 102 | 9 360 | 11 121 | 11 675 | 13 637 | 14 544 |
| Equity | 887 | 1 025 | 1 040 | 735 | 735 | 850 | 825 | 825 | 825 | 825 |
| Long-term debt | 387 | 812 | 712 | 632 | 632 | 632 | 582 | 0 | — | 0 |
| Short-term debt | 2 076 | 2 642 | 4 467 | 5 819 | 6 735 | 7 878 | 9 714 | 10 850 | 12 813 | 13 719 |
| Total debt | 2 463 | 3 454 | 5 179 | 6 451 | 7 367 | 8 510 | 10 296 | 10 850 | 12 813 | 13 719 |
EBITDA margin
-151400000.0%
This company
15.8%
Market median
-958227948% vs market
20152024
Equity ratio
5.7%
This company
38.2%
Market median
-85% vs market
20152024
Return on equity
-183.5%
This company
18.4%
Market median
-1097% vs market
20152024
Net profit margin
-151400000.0%
This company
8.1%
Market median
-1869135902% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
16.63×
This company
0.62×
Market median
-2582% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CG Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
KA Chief Auditor | Chief Auditor | 2020 | — | — |
LU Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Kiwok Nordic Ab (Publ) | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Kiwok Nordic Ab (Publ)
Kiwok Development AB Board members of Kiwok Development AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claes Göran Carlsson | Chief Executive Officer | 0 companies |
| Karl Anders Håkansson | Chief Auditor | 0 companies |
| Lars Uno Peter Åberg | Chief Executive Officer | 0 companies |
| Anders Mikael Östlund | Chairman | 0 companies |
| Klas Ingvar Nyström | Board of Directors | 0 companies |
| Björn-Erik Erlandsson | Board of Directors | 0 companies |